Clinical-Trials Books
Related Subjects:
More Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188

Used price: $116.38

Most complete reference on the topicReview Date: 2006-09-06
DisappointedReview Date: 2008-02-19
Used price: $49.98

I use this every day !Review Date: 2001-08-17
Skimpy, minimalist definitions and overpricedReview Date: 2002-02-19

Used price: $240.73

Miss 19 pagesReview Date: 2007-01-03

Used price: $4.93

Szasz's ItReview Date: 2008-07-02
The book is primarily concerned with the issue of involuntary confinement in state mental hospitals, the legality and the morality of this. When this book was written most states had either begun or were in the process of releasing a great many of their state mental hospital patients in what has been called deinstitutionalization. Now very few state mental hospitals exist.
Szasz's arguments are, at times, cogent and respectable. His empathy for humankind and freedom and America as a free nation is attractive and made of the very best intentions. This book was not concerned with the veracity of mental illness as an illness (which Szasz has questioned in his other books) but instead only with involuntary confinement - or simply confinement - in state mental hospitals - or any hospitals. He likens the involuntary committed mental hospital patients as slaves in the way blacks were before slavery was completely outlawed in the Constitution. Now he wants the same thing for psychiatry - ban it, outlaw it, throw it away.
Szasz is using the guilt-trip method of argument, so to speak. He's yelling at his audience through the paper to get up and do something about this inhumanity because after all if you don't, you're to blame. His writing style is not academic but radical, angry. Time after time he refers to psychiatrists as performing "mad-doctoring" of being "wardens" in the state mental hospital which, in his estimation, is a prison. He tares apart the American Psychiatric Association on one page, and the American Civil Liberties Union on the next.
Szasz, who is a fully trained psychiatrist, was popular because he was seen as an expert, and not just a fool with an opinion. These days his views are seen as insincere, smug and impractical. And, the Church of Scientology, which has become enlivened in recent years with its celebrity converts, uses Szasz's many arguments on the falsehood of mental illness to promote their own agenda.
Speaking from how well Szasz presents his argument, his writing and so forth, the book is not especially bad. There are some good points made about state mental hospitals involuntarily committing patients, which the American public must be made aware of. And they were, because at this present time well over 90% of all state mental hospital patients have been released. Psychiatry is done on an outpatient basis nowadays, and most mentally ill people prefer this and get benefit from this. Although I cannot recommend this book; ideologically speaking, it'd be like a Jew recommending Mein Kampf. I can't do it and I won't do it.
Points out many inconsistencies regarding the Donaldson caseReview Date: 2003-01-10
Donaldson was institutionalized because he told his parents that the neighbors were trying to poison him. Although his parents sent him to an asylum for this, Donaldson maintained he was not mentally disturbed.
The American Civil Liberties Union (ACLU) assisted Donaldson in attempting to gain his freedom, but in a bizarre way. Although Donaldson wanted nothing to do with medication and shock therapy, he sued the hospital director because he was not receiving treatment. From the data presented, I got the impression that the ACLU used Donaldson for their own ends, which was to strengthen the power of psychiatry.

Used price: $57.95

Completely disagree with the previous reviewReview Date: 2007-12-18
I have come to understand that there is no one "perfect" book on statistics. For example, I own probably around 15 books on various topics in statistics. Why? Because different authors did best with different ways of presenting the material, explanations, and topics themselves. This book is no exception. There are some good things, there are some things that could have been clearer. Where this book wins is if you need a source to quickly look something up - it is a definite thumbs-up. But if you need to "learn" then buy other texts.
A plethora of errorsReview Date: 2007-06-15
Explanations of tests are either Byzantine or absent. On page 27, the way they set up the Wilcoxon Rank Sum test is so unorthodox as to make it incomprehensible. On page 54, the output of four different post ANOVA tests are shown and extensively mentioned in the narrative. But, there are no explanation whatsoever on the underlying test calculations.
The above caused me to distrust everything about this book. If I picked up so many mistakes within the material I know, how many more are there among the material I don't know.
The purpose of reading statistics books is to acquire reliable knowledge. That book failed on this count. If you are interested in the underlying statistics of clinical trials I recommend instead Intuitive Biostatistics. This is an excellent and occasionally challenging book. Be sure you have a good foundation in basic statistics before studying it. For basic statistics I recommend Forgotten Statistics.

Used price: $29.70

Not a good book and insane priceReview Date: 2007-02-23
Management of Data in Clinical Trials (Wiley Series in ProbaReview Date: 2002-03-11
Out of DateReview Date: 2004-02-27

Used price: $170.90

It is what it says it is....a "practical" guideReview Date: 2008-09-15
not unusual for books in clinical data managementReview Date: 2008-02-28
Useless bookReview Date: 2007-09-25
However, it is a collection of facts and bulleted lists of things to do while conducting a clinical trial and I still do not find a single tangible example. This makes all that is written impossible to grasp and understand.
Also, have you ever seen a book without a reference list? Well, this is the first book I have ever read that is not a fiction book that does not have a single reference nor a reference list at the end of the book or of each chapter. This makes the book almost completely useless.
One could pardon typographical errors such as "this data" if the book was better. In this context, this kind of typos only give an extended idea of the bad quality of this book.
I feel as if I wasted my money and time reading it.


Good as far as it goesReview Date: 2008-02-10
This book feels very disorganized, with little help from the index and contents. There are much better books of this type on the market - for example, Primer of Biostatistics by Stanton A. Glantz or even Epidemiology by Leon Gordis. I'd keep looking.

Used price: $10.94

Handbook of Clinical TrialsReview Date: 2007-12-11

This book offers nothing!Review Date: 2003-08-29
I've never seen a garbage like this beforeReview Date: 2002-02-07
this is not a book on statistical methodsReview Date: 2001-12-14
It is true that most clinical trials are conducted on restricted sets of subjects who must meet carefully planned inclusion/exclusion criteria. Also, clinical centers are chosen by the sponsor (often a pharmaceutical company) and are picked because they have performed well in the past or have a well known investigator. Therefore, the common paradigm of statistical inference that the subjects are a random sample from a larger population is not even closely true. This seems to be a good argument for not taking formal statistical hypothesis testing too seriously in this context and too much attention has been placed on p-values and rigid decision making in the regulatory arena so I was very much interested in seeing how Norleans would get around these problems.
But instead of recognizing the inadequacies of the models and finding better models, he resorts to a subjective form of decision making based solely on graphics and a misunderstanding of methods such as maximum likelihood and analysis of variance. These problems require increased sophistication for solution not the abandonment of statistical modeling.
Graphical techniques are clearly useful and the pioneering work of Tukey led to a deeper appreciation for good exploratory data analysis techniques beginning in the 1960s. However, Norleans ignores or is ignorant of this literature as he fails to use any of the techniques of Tukey. Rather he concentrates on unconventional and not always very informative graphical displays. These techniques seem to be designed to look at individuals more than groups and can often be very cluttered. There is no reference to Tukey, Cleveland or Tufte, the pioneers in statistical graphics.
I find his condemnation of Jerzy Neyman particularly insulting and it shows both naivety and lack of understanding. He doesn't even know how to spell Neyman's first name (sic Jersey)! He claims that statistical hypothesis testing is based on assuming the truth can be known when in fact it is just the opposite. The framework assumes that there is a true state of nature but the truth can never be known and that we can only express our degree of belief in probabilities that particular decision rules lead to incorrect conclusions. Sample size requirements and decisions are made when these error probabilities are sufficiently small.
Neyman-Pearson theory has also been criticized for using a sharp null hypothesis but extensions of the theory got around that problem as can be seen from the famous text by Lehmann on hypothesis testing in the late 1950s. It is commonplace now to use both composite null and alternative hypotheses and appropriate methods for equivalence teting have been devised by switching the usual null and alternative hypothesis. But Norleans appears to be unaware of these advances. Also the generalization by Wald and others to statistical decision theory based on loss functions or utility functions is likewise overlooked.
On the one hand he reject parametric statistical inference because he does not believe in the use of parametric distributions to represent test statistics but yet he accepts the method of maximum likelihood which he does not recognize as parametric. But maximum likelihood methods are not always robust and in some cases not even sensible.
The analysis of clinical trials is challenging. Mixed effects models, censored survival models, handling of missing data, multiplicity adjustment are among the many tools and issues associated with these problems. Probability and statistics have subtleties that cannot always be simplified. It takes sophistication and the clever use of probability to conquer these problems but Norleans offers us none of this.
He appears to be ignorant of the asymptotic theory of statistics which is based on convergence concepts from probability. The only asymptotic result he mentions is the central limit theorem and that he seems to think is based on a Taylor series approximation. With the Poisson model he mentions the problem of overdispersion but instead of recognizing that with medical data more complex models such as compound Poisson can adequate address the issue and make sense clinically he rejects the methodology itself.
Medical researchers who want to understand statistics and its useful role in medicine and other research would be better served by reading David Salsburg's "A Lady Tasting Tea" than the garbage in this book.
I really have serious issue about Dr. Chow's selection of this book for this series and I cannot understand how he can characterize it so favorably in his introduction.
not worth the paper it is printed onReview Date: 2007-08-18
Because it is so easy for prospective buyers to be misled into purchasing this book for the reasons I have given and because editorial reviews are just sugar-coated publisher sales pitches that are also very misleading I continue to warn amazon readers not to waste their money on this book!
Related Subjects:
More Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188
There are a few strengths that are particularly worth pointing out:
1) Makes many references to regulatory guidelines.
2) Excellent coverage of the various trial designs.
3) Good sample size chapter.
4) Several chapters on how to practically implement a trial.
Other options include:
-Piantodosi (Clinical Trials: methodologic perspective): my second favorite, not as comprehensive as Chow and Liu
-Freidman and DeMets (Fundamentals of Clinical Trials): a bit too superficial but very well written
-Pocock (Clinical trials: practical approach): a bit dated and superficial